dabigatran
PREFER-AF
Phase 3 small_molecule active
Quick answer
dabigatran for Atrial Fibrillation is a Phase 3 program (small_molecule) at Yung NA with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Yung NA
- Indication
- Atrial Fibrillation
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active